Abstract. Human p12CDK2AP1 protein is encoded by the cyclin-dependent kinase 2-associated protein 1 (CDK2AP1) gene. This protein suppresses cell growth, differentiation and angiogenesis in numerous types of carcinoma by interacting with certain cell cycle proteins, including CDK2 and DNA polymerase α/primase. p12 CDK2AP1 exerts its functions predominantly through protein-protein interactions. Therefore, the identification of other p12 CDK2AP1 -interacting proteins may clarify its role in cell cycle regulation and carcinogenesis. The aim of this study was to identify additional p12 CDK2AP1 -interacting proteins. A novel unnamed protein product (UPP, BC006130) was identified through using a yeast two-hybrid system. The interaction of p12 CDK2AP1 with the UPP was further verified by glutathione S-transferase pull-down and co-immunoprecipitation experiments in vitro. The qPCR results following overexpression and siRNA assays demonstrated that the expression levels of the UPP were mediated by the CDK2AP1 gene. Furthermore, overexpression of the UPP gene was shown to shorten the length of the G2/M phase of the cell cycle in normal and tumor cell lines in a flow cytometry assay. The results of human tumor xenografts experiments in Balb/c nude mice indicated that stable transfection with the UPP gene was able to inhibit tumor cell proliferation in vivo. Overall, this study identified and characterized a novel interactive protein of p12 CDK2AP1 , which may inhibit cell proliferation by mediating the cell cycle. It expands the understanding of the mechanisms of p12 CDK2AP1 and its potential as a cancer therapeutic target.
IntroductionCyclin-dependent kinase 2-associated protein 1 (CDK2AP1) is a putative growth suppressor gene originally identified and isolated from normal keratinocytes (1). The human CDK2AP1 gene is 1.6 kb long and is located on chromosome 12q24.31 (2). The human and rodent polypeptides encoded by the CDK2AP1 gene share 97% identity, while the mouse and hamster sequences are identical (3). Human CDK2AP1 encodes a 115-amino acid peptide with a molecular mass of 12.4 kDa (pI 9.62), namely p12 CDK2AP1 (4). Previous studies have demonstrated that p12 CDK2AP1 negatively regulates cell growth by sequestering the monomeric non-phosphorylated form of CDK2 and targeting it for proteolysis to reduce the active pool of CDK2 in cells (5). The protein also reduces CDK2-mediated retinoblastoma protein phosphorylation by reversing the activity of TGF-β (6). A previous study has demonstrated that miR-21 downregulates p12 CDK2AP1 to stimulate cell proliferation and invasion (7). These observations indicate that p12 CDK2AP1 acts as a growth suppressor through influencing mitosis, the S phase and the cell division cycle. A study has demonstrated that p12 CDK2AP1 is also important in promoting Oct4 promoter methylation during murine embryonic stem cell differentiation and thereby downregulates Oct4 expression levels (8